H Mesquita Gabriel

Summary

Country: Portugal

Publications

  1. ncbi request reprint Role of abciximab in the treatment of coronary artery disease
    H Mesquita Gabriel
    Unidade de Cardiologia de Intervenção Joaquim Oliveira, Servico de Cardiologia, Hospital de Santa Maria, Avenida Egas Moniz, 1649 035 Lisboa, Portugal
    Expert Opin Biol Ther 6:935-42. 2006
  2. ncbi request reprint Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early ReoPro administration in myocardial infarction (ERAMI) trial
    H Mesquita Gabriel
    Servico de Cardiologia, Hospital de Santa Maria, Lisbon, Portugal
    Catheter Cardiovasc Interv 68:218-24. 2006

Detail Information

Publications2

  1. ncbi request reprint Role of abciximab in the treatment of coronary artery disease
    H Mesquita Gabriel
    Unidade de Cardiologia de Intervenção Joaquim Oliveira, Servico de Cardiologia, Hospital de Santa Maria, Avenida Egas Moniz, 1649 035 Lisboa, Portugal
    Expert Opin Biol Ther 6:935-42. 2006
    ..It is used for treatment of coronary artery disease, being well-studied in the setting of acute coronary syndromes and percutaneous coronary intervention, in which a rapid and effective antiaggregation is clinically important...
  2. ncbi request reprint Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early ReoPro administration in myocardial infarction (ERAMI) trial
    H Mesquita Gabriel
    Servico de Cardiologia, Hospital de Santa Maria, Lisbon, Portugal
    Catheter Cardiovasc Interv 68:218-24. 2006
    ..We assessed the safety and efficacy of early administration of abciximab prior to percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) patients...